USANA Health Sciences, Inc. (USNA)
NYSE • Consumer Defensive
Last close at September 4, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q3 2026In plain terms: out of every $100 in revenue, USANA Health Sciences, Inc. currently loses $10.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 28
in 54 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
USANA Health Sciences’ revenue missed Wall Street’s view in the second fiscal quarter of 2026, reported Aug. 4 based on preliminary results, as about $223.3 million came in below the $235.0 million estimate by about 5% and was down 5.3% from $235.8 million a year ago. Gross profit reached about $174.9 million, with gross margin near 78.3%, while operating cash flow was $9.8 million. For the next period, consensus calls for EPS of $0.43 on revenue of $224.7 million.
About USANA Health Sciences, Inc.
USANA Health Sciences, Inc. sells nutritional and personal-care products through direct selling, subscriptions, online orders, and retail channels, operating in consumer staples with a focus on household and personal care. On the NYSE as USNA, it generated $925.3 million of revenue in FY2025.
Today's Snapshot
The day ended with USNA 3.7% higher at 14.96.
Trading Volume
Above 10d avg 209.6K
224.8K
vs S&P 500 Today
Strong Outperformance
+4.09%
Updated: September 4, 2026 at 20:18 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$14.32 - $19.59Sell
- RSI (14)45.97Neutral
- Stochastic %K (14, 3, 3)89.21Sell
- MACD Level (12, 26)-0.99Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.